| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/19/2000 | EP0972021A1 Extracellular/epidermal growth factor like protein |
| 01/19/2000 | EP0972020A1 Insulin-like growth factor agonist peptides |
| 01/19/2000 | EP0971917A1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties |
| 01/19/2000 | EP0971908A1 Il-8 receptor antagonists |
| 01/19/2000 | EP0971885A1 Process for preparing indane-like compounds |
| 01/19/2000 | EP0971880A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid |
| 01/19/2000 | EP0971641A1 Intravesical drug delivery system |
| 01/19/2000 | EP0971588A1 Novel cannabinoid receptor modulators |
| 01/19/2000 | CN1242006A Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/19/2000 | CN1241999A Vitamin D3 derivatives |
| 01/19/2000 | CN1241997A Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 01/19/2000 | CN1048499C Process for preparing appropriate salt of 11 beta-aryl-4-estrene pharmaceutical composition |
| 01/19/2000 | CN1048484C A process for preparing a composition containing benzoheterocycles |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015819 Administering adrenergic blocking agent; reduction of orthostatic fall in blood pressure side effect; fda orange book listed patent for silodosin |
| 01/18/2000 | US6015818 Quinoline derivatives as bradykinin agonists |
| 01/18/2000 | US6015685 Ancrod proteins, their preparation and use |
| 01/13/2000 | WO2000001702A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001701A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001676A1 Potassium channel blocking agents |
| 01/13/2000 | WO2000001668A2 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 01/13/2000 | WO2000001389A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/13/2000 | WO2000001382A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001238A1 Methods for eradication of nanobacteria |
| 01/13/2000 | DE19830431A1 Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators |
| 01/13/2000 | CA2336714A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/13/2000 | CA2336475A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336448A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336054A1 Inhibitors of prenyl-protein transferase |
| 01/12/2000 | EP0970112A2 Novel human cytokine/steroid receptor protein |
| 01/12/2000 | EP0970073A1 Process for preparing eprosartan |
| 01/12/2000 | EP0969737A1 Pet food composition |
| 01/12/2000 | CN1241177A Substed. 4-biphenyl-4-hydroxybutyric acid derivs. as matrix metalloprotease inhibitors |
| 01/12/2000 | CN1048159C Method for preparing pharmaceutical composition contg. imidazolyl-alkenoic acid |
| 01/11/2000 | US6013497 Polynucleotide sequence that codes a polypeptide; bactericides |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/06/2000 | WO2000000510A2 Growth factor modulators |
| 01/06/2000 | WO2000000197A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 01/06/2000 | CA2331399A1 Thienopyridine compounds, their production and use |
| 01/06/2000 | CA2330565A1 Growth factor modulators |
| 01/06/2000 | CA2327888A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 01/05/2000 | EP0968208A1 Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia |
| 01/05/2000 | EP0666856B1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 01/05/2000 | DE19828113A1 Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV Prodrugs of inhibitors of dipeptidyl peptidase IV |
| 01/05/2000 | CN1240424A Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 01/04/2000 | US6011059 Acyl guanidine sodium/proton exchange inhibitors and method |
| 01/04/2000 | US6011057 Methods for inhibiting uterine fibroid disease |
| 01/04/2000 | US6011055 Administering indomethacin, naproxen, ibuprofen, tenidap and imiquod in a pharmacologically acceptable carrier, excipient or diluent. |
| 01/04/2000 | US6011051 Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 01/04/2000 | CA2194103C Polypeptides useful as calcium channel blockers |
| 12/29/1999 | WO1999067384A2 Prostate cancer-associated genes |
| 12/29/1999 | WO1999067363A1 Ependymal neural stem cells and method for their isolation |
| 12/29/1999 | WO1999067359A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 12/29/1999 | WO1999067279A1 Compounds of unstable dipeptidyl peptidase iv inhibitors |
| 12/29/1999 | WO1999067278A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 12/29/1999 | WO1999067236A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/29/1999 | WO1999066917A2 Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid |
| 12/29/1999 | WO1999055339A8 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function |
| 12/29/1999 | EP0966525A1 Method of using tetracycline compounds for inhibition of nitric oxide production |
| 12/29/1999 | EP0966295A1 Calcareous material |
| 12/29/1999 | EP0625048B1 Synthesis of human procollagens and collagens in recombinant dna systems |
| 12/29/1999 | EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 12/29/1999 | CN1239962A 1,4-diazabicyclo [2,2,2] oct-2-ylmethyl derivatives, their preparation and therapeutic application |
| 12/29/1999 | CN1239952A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors |
| 12/29/1999 | CA2335992A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 12/29/1999 | CA2335978A1 Compounds of unstable dipeptidyl peptidase iv inhibitors |
| 12/29/1999 | CA2335545A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 12/29/1999 | CA2331769A1 Prostate cancer-associated genes |
| 12/29/1999 | CA2330189A1 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 12/29/1999 | CA2330175A1 Ependymal neural stem cells and method for their isolation |
| 12/29/1999 | CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/28/1999 | US6008017 Human cardiac/brain tolloid-like protein |
| 12/28/1999 | US6007821 Immunosuppression; organ transplants, insulin dependent diabetes |
| 12/23/1999 | WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 12/23/1999 | WO1999065942A1 Cyclic somatostatin analogs |
| 12/23/1999 | WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12 |
| 12/23/1999 | WO1999065922A2 Prenyl transferase inhibitors |
| 12/23/1999 | WO1999065898A1 Imidazolyl derivatives |
| 12/23/1999 | WO1999065887A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 12/23/1999 | WO1999065877A1 Therapeutic biaryl derivatives |
| 12/23/1999 | WO1999065523A1 Immunotherapeutic composition and method for the treatment of prostate cancer |
| 12/23/1999 | WO1999065521A1 Methods and materials for the treatment of prostatic carcinoma |
| 12/23/1999 | DE19825591A1 Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata Pharmaceutical combinations to offset a deficit testosterone in men with prostate while protecting the |
| 12/23/1999 | CA2337603A1 Prenyl transferase inhibitors |
| 12/23/1999 | CA2335435A1 Imidazolyl derivatives |
| 12/23/1999 | CA2335337A1 Methods and materials for the treatment of prostatic carcinoma |
| 12/23/1999 | CA2335184A1 Cyclic somatostatin analogs |
| 12/23/1999 | CA2334254A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 12/23/1999 | CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 12/23/1999 | CA2331382A1 Interaction of p27(kip1) with fkbp-12 |
| 12/23/1999 | CA2328504A1 Immunotherapeutic composition and method for the treatment of prostate cancer |
| 12/22/1999 | EP0965595A1 Protein complex |
| 12/22/1999 | EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 12/22/1999 | EP0964852A1 Indolecarboxylic compounds and their use as pharmaceutical compounds |
| 12/22/1999 | EP0964691A1 Use of conantokins |
| 12/22/1999 | EP0964678A1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions |
| 12/22/1999 | CN1239510A Compsns. and methods for treating disease states with myeloid progenitor inhibitory factor-1(MPIF-1), monocyte colony inhibitory factor (M-CIF) and macrophage inhibitory factor-4(MIP-4) |
| 12/22/1999 | CN1239431A Immunogenic TLP compsn. |
| 12/21/1999 | US6005117 Imino compounds, process for their preparation and their use as victronectin antagonists |